Royce & Associates’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
195,000
+40,000
+26% +$387K 0.02% 592
2025
Q4
$1.57M Buy
+155,000
New +$1.54M 0.02% 624

Other funds holding DCTH

Royce & Associates's DCTH Position: Q1 2026 in Review

Royce & Associates increased its Delcath Systems (DCTH) stake by 26% in Q1 2026, buying an estimated $387K and bringing the position to 195,000 shares worth $1.81M. The position accounts for 0.02% of the portfolio, ranked #592.

Royce & Associates first reported a position in DCTH in Q4 2025 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • Royce & Associates held 195,000 shares of Delcath Systems worth $1.81M as of Q1 2026.
  • Royce & Associates bought 40,000 Delcath Systems shares in Q1 2026, an estimated $387K.
  • Delcath Systems made up 0.02% of Royce & Associates's portfolio in Q1 2026, its #592 holding.
  • Royce & Associates first reported a position in Delcath Systems in Q4 2025 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.